Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 22 NETWORK 1 INDUSTRY 1

Study Type

Interventional 176 Observational 1

Sponsor

Cancer Type

Conditions

Interventions

Gene Expression Profiling 74 Polymerase Chain Reaction 44 Microarray Analysis 40 Amplified Fragment Length Polymorphism Analysis 37 Immunohistochemistry 35 Flow Cytometry 30 Reverse Transcriptase Polymerase Chain Reaction 22 DNA Methylation 16 Blotting, Western 15 Cytogenetic Analysis 14 Base Sequence 12 Psychiatric Rehabilitation 11 In Situ Hybridization, Fluorescence 10 Immunologic Techniques 9 Enzyme-Linked Immunosorbent Assay 7 Mental Status and Dementia Tests 6 Comparative Genomic Hybridization 6 Watchful Waiting 5 Specimen Handling 5 Pharmacogenomic Testing 5 Mass Spectrometry 5 Gene Rearrangement 5 Chromosome Mapping 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Rituximab 4 Paclitaxel 4 Interviews as Topic 4 In Situ Hybridization 4 Immunoenzyme Techniques 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Observational × Doxorubicin × Clear all

NCT02986503 2016-12-08

EUROBOSS

Italian Sarcoma Group

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡